IL273996A - Dosing regimens for use with pcsk9 inhibitors - Google Patents
Dosing regimens for use with pcsk9 inhibitorsInfo
- Publication number
- IL273996A IL273996A IL273996A IL27399620A IL273996A IL 273996 A IL273996 A IL 273996A IL 273996 A IL273996 A IL 273996A IL 27399620 A IL27399620 A IL 27399620A IL 273996 A IL273996 A IL 273996A
- Authority
- IL
- Israel
- Prior art keywords
- dosing regimens
- pcsk9 inhibitors
- pcsk9
- inhibitors
- regimens
- Prior art date
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361902857P | 2013-11-12 | 2013-11-12 | |
US201461955337P | 2014-03-19 | 2014-03-19 | |
EP14306222 | 2014-07-31 | ||
PCT/US2014/065149 WO2015073494A1 (en) | 2013-11-12 | 2014-11-12 | Dosing regimens for use with pcsk9 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL273996A true IL273996A (en) | 2020-05-31 |
Family
ID=69737471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL273996A IL273996A (en) | 2013-11-12 | 2020-04-16 | Dosing regimens for use with pcsk9 inhibitors |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2020037566A (en) |
ES (1) | ES2864350T3 (en) |
IL (1) | IL273996A (en) |
TW (1) | TW202017595A (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3672B1 (en) * | 2008-12-15 | 2020-08-27 | Regeneron Pharma | High Affinity Human Antibodies to PCSK9 |
-
2014
- 2014-11-12 TW TW108121533A patent/TW202017595A/en unknown
- 2014-11-12 ES ES14810057T patent/ES2864350T3/en active Active
-
2019
- 2019-11-06 JP JP2019201184A patent/JP2020037566A/en active Pending
-
2020
- 2020-04-16 IL IL273996A patent/IL273996A/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW202017595A (en) | 2020-05-16 |
ES2864350T3 (en) | 2021-10-13 |
JP2020037566A (en) | 2020-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL245564A0 (en) | Dosing regimens for use with pcsk9 inhibitors | |
IL268180A (en) | Anti-folr1 immunoconjugate dosing regimens | |
ZA201902009B (en) | Anti-folr1 immunocunjugate dosing regimens | |
HK1219475A1 (en) | Neprilysin inhibitors | |
EP2948458A4 (en) | Btk inhibitors | |
EP2970340A4 (en) | Beta-lactamase inhibitors | |
EP2943204A4 (en) | Beta-lactamase inhibitors | |
PL2798995T3 (en) | Dosing device | |
EP2948431A4 (en) | Btk inhibitors | |
HK1216531A1 (en) | Novel inhibitors | |
GB201314578D0 (en) | Bicyclic inhibitors | |
EP3012425A4 (en) | Urea water suitability determination device | |
GB201305517D0 (en) | Materials for use in chemical looping combustion | |
LT3024825T (en) | Imidazolecarboxamides and their use as faah inhibitors | |
IL273996A (en) | Dosing regimens for use with pcsk9 inhibitors | |
ES1096306Y (en) | CONTAINER PLUG | |
GB201304599D0 (en) | Dosing regimen | |
GB201318502D0 (en) | Determining nagalase concentration | |
GB201311875D0 (en) | Activity level device |